offline
Zoetis (ZTS) Q4 Earnings and Revenues Beat Estimates
Zoetis (ZTS) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.79 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 4.55%. A quarter ago, it was expected that this animal health company would post earnings of $0.89 per share when it actually produced earnings of $0.94, delivering a surprise of 5.62%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Zoetis, which belongs to the Zacks Medical - Drugs industry, posted revenues of $1.67 billion for the quarter ended December 2019, surpassing the Zacks Consensus Estimate by 2.12%. This compares to year-ago revenues of $1.56 billion.
...
https://finance.yahoo.com/news/zoetis-zt...01660.html
![[Bild: ZTSc1dl1600.png]](https://finviz.com/publish/021720/ZTSc1dl1600.png)
Zoetis (ZTS) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.79 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 4.55%. A quarter ago, it was expected that this animal health company would post earnings of $0.89 per share when it actually produced earnings of $0.94, delivering a surprise of 5.62%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Zoetis, which belongs to the Zacks Medical - Drugs industry, posted revenues of $1.67 billion for the quarter ended December 2019, surpassing the Zacks Consensus Estimate by 2.12%. This compares to year-ago revenues of $1.56 billion.
...
https://finance.yahoo.com/news/zoetis-zt...01660.html
__________________
